The off-label use of antineoplastics in oncology is limited but has notable scientific support in a university hospital setting

  1. Fernandez, M.H.
  2. Villaverde, R.M.
  3. Yustos, M.A.
  4. Expósito, F.N.
  5. Gonzalez, J.L.L.
  6. Infantes, M.R.L.
  7. Soto, M.A.-M.
Journal:
Frontiers in Pharmacology

ISSN: 1663-9812

Year of publication: 2019

Volume: 10

Issue: OCT

Type: Article

DOI: 10.3389/FPHAR.2019.01210 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus